AstraZeneca Says Its COVID-19 Vaccine Produces Robust Immune Response In Elderly Patients | Zero Hedge

Days after US regulators gave the AstraZeneca-Oxford vaccine the green light to re-start its US-based trials, the FT is reporting new data that seems promising, even if it’s still pretty preliminary.
— Read on

Leave a Reply